Shares of IO Biotech Rise 14.5% Premarket After Reuters Reported Jefferies Initiated Coverage With a Buy Rating, $20 Price Target

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.